Join BOPA
Back to news articles

My Research Webinar: Understanding global participation in gynae-oncology RCTs: a systematic review approach

By BOPA Research Committee on 9th September 2024

Wednesday 25th September 2024 13:00 GMT

 

Register for the Session HERE: https://www.bopa.org.uk/webinarsignupform/

 

We would like to invite you to join our  ‘My Research’ sessions. These sessions are delivered by members that have undertaken an audit or evaluation. They will spend time describing their career pathway and discuss the research methods that they used. There will be time for detailed questions following the talk. These sessions will enable members to learn about quantitative and qualitative methods and the learning may guide and help you in your future projects. We also hope that this will be a good opportunity to learn about different career pathways in cancer pharmacy.

 

Title: Understanding global participation in gynae-oncology RCTs: a systematic review approach

The session will be delivered by: Luke Steventon

Biography

Luke is a researcher at University College London Hospital and a part-time PhD student at the University College London School of Pharmacy. He collaborates with the Benefits and Risks of Cancer Treatment team in Oxford Population Health on studies of outcomes after chemotherapy. His PhD studies focus on treatment effects of systemic therapies for gynaecological cancers. Other research activities include the development of a predictive model of renal and hepatic function for patients on chemotherapy, the impact of chemotherapy delays on survival outcomes, and management of a quality improvement project aiming to widen access to bispecific antibodies for myeloma patients

 

Please Note:

-Webinars will start at 13:00 GMT and will last about 30 minutes to 1 hour

-The Zoom link for the webinar will be sent on the day of the event around 12:00pm (if you would like the link before this time please email [email protected])

-This webinar is FREE to access for BOPA Paid Members or Free Associates

-Webinars will be recorded and appear in the BOPA eLearning section of the website via this LINK

 

The BOPA Research Subcommittee

Latest News

By BOPA Executive Committee on 25th April 2025

NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.

BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…

Read article
By BOPA IO SAG on 23rd April 2025

Toolkit for Immunotherapy IV to SC switch

Dear all, In the coming months, an increasing number of products traditionally administered intravenously are expected to become available for subcutaneous administration. This shift offers enhanced flexibility for patients; however,…

Read article
By BOPA E&T subcommittee on 17th April 2025

The BOPA Cancer Consultant Pharmacist Credentialing Support Series is back

BOPA are holding a nine month supportive webinar series for pharmacists who are credentialing as consultant pharmacists with the RPS. Join in this relaxed forum to discuss about your portfolio…

Read article
By BOPA research subcommittee on 17th April 2025

Celebration of BOPA member’s recent publications

We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then…

Read article